Showing results (481-490 of 530) with videos related to

Sort By:
Pageof 53
The Lancet. Neurology|May 17, 2024
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trialBruce A C Cree, Ho Jin Kim, Brian G Weinshenker, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 26, 2019
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic reviewClaire Tochel, Michael Smith, Helen Baldwin, et al.
Human Heredity|July 10, 2010
Genetic differences between five European populationsValentina Moskvina, Michael Smith, Dobril Ivanov, et al.
Cancer|September 15, 2020
Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer CenterStefanos Boukovalas, Ryan P Goepfert, J Michael Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2023
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentumBrian G Weinshenker, Dean M Wingerchuk, Ari J Green, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 14, 2024
Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacementSyeda A Hasan, Moustafa Morsi, Belinda S Frakes, et al.
Life Sciences in Space Research|September 10, 2017
The radiation environment on the surface of Mars - Summary of model calculations and comparison to RAD dataDaniel Matthiä, Donald M Hassler, Wouter de Wet, et al.
Endoscopy|June 10, 2020
Expert assessment on volumetric laser endomicroscopy full scans in Barrett's esophagus patients with or without high grade dysplasia or early cancerMaarten Struyvenberg, Allon Kahn, David Fleischer, et al.
Vaccines|February 26, 2026
Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year OldsJulia Glanternik, Grant C Paulsen, Shelly Senders, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorderRomain Marignier, Sean J Pittock, Friedemann Paul, et al.
Pageof 53